Phase 3 Study of Carboplatin and Vincristine

A Phase 3 Study of Carboplatin and Vincristine versus Selumetinib) in Newly Diagnosed or Previously Untreated Low-Grade Glioma (LGG) not associated with BRAFV600E Mutations or Systemic Neurofibromatosis Type 1 (NF1)